ANZCTR search results

These search results are from the Australian New Zealand Clinical Trials Registry (ANZCTR).

You can narrow down the results using the filters

31330 results sorted by trial registration date.
  • The effect of talocrural mobilisation with movement on ankle dorsiflexion and knee valgus during squatting in individuals with a history of ankle sprains

    This study aims to investigate the effects of ankle mobilisations on ankle dorsiflexion ROM and its relationship to hip adduction and knee valgus in a single leg squat. Participants will be assessed before and after 6 treatment sessions over a 3 week period. Our primary aim is to determine the effect of ankle mobilisations on ankle dorsiflexion and knee valgus angle during squatting. A secondary aim is to determine whether a change in dorsiflexion range of motion following the first treatment predicts a change in dorsiflexion range of motion following the final treatment session.

  • Intravenous midazolam-droperidol (combination), droperidol (only) or olanzapine (only) for the acutely agitated patient: A multi-centre, randomised, double-blind, controlled, clinical trial

    We believe that the combination of midazolam and droperidol will be superior in efficacy and safety to droperidol alone or olanzapine alone for patients with acute agitation

  • Reducing the impact of aphasia in stroke patients and their caregivers a year post onset via a brief early intervention: a cluster randomised control trial of the Aphasia Action Success Knowledge (ASK) program.

    The overarching aim of this study is to decrease the incidence of depressive symptoms for people with aphasia and their caregivers. The specific aims are to determine whether a tailored, early intervention program (Aphasia ASK) leads to better mood and overall quality of life outcomes than an attention control (a secondary stroke prevention intervention) at 12 months post-stroke in both patients with aphasia and their caregivers.

  • The feasibility and safety of inspiratory muscle training for patients with acute spinal cord injury

    This study investigates the feasibility and safety of inspiratory muscle training for patients with early spinal cord injury. Patients with spinal cord injury are at high risk of respiratory complications. Inspiratory muscle training is a technique that can be used to improve the respiratory function of patients with spinal cord injury but, to date, research published about its feasibility, safety and effectiveness has only included patients who are some weeks or month post-injury. The purpose of this interventional study is to investigate the feasibility and safety of inspiratory muscle training for patients with acute spinal cord injury. The specific aims are to document, in patients with acute spinal cord injury: the feasibility of inspiratory muscle training by recording the number of physiotherapy sessions where the criteria to participate in inspiratory muscle training are met and the number of physiotherapy sessions where the criteria to participate in inspiratory muscle training are not met (and reasons why); the safety of inspiratory muscle training by recording parameters such as haemodynamic stability, oxygenation, breathlessness and respiratory complications; the effect of inspiratory muscle training on lung function parameters such as inspiratory strength and lung volumes.

  • Tools for resilience: A mobile phone and web-based intervention for improving mental wellbeing and reducing distress in adolescents and young adults with Type 1 diabetes

    Young people with Type 1 diabetes are at greater risk of mental health problems and poor psychological wellbeing than their counterparts without diabetes. Young people are high users of mobile and internet-technology, and increasingly use these tools for health information and support. The project’s primary objective is to test the hypotheses that psychological well-being will be significantly improved, and that symptoms of psychological (i.e., depression, anxiety and stress) and diabetes-related distress will be significantly reduced, in participants who use a mobile phone and web-based mental health intervention, myCompass, for seven weeks compared with those in a placebo control group. The project’s secondary objective is to test the hypothesis that diabetes self-care, work and social functioning, glycaemic control (glycosylated haemoglobin, HbA1c), and quality of life will be significantly improved for participants who receive the myCompass intervention.

  • A play-based intervention to improve the social play skills of children with Attention Deficit Hyperactivity Disorder (ADHD)

    The purpose of the 10-week play-based intervention is to improve the social and communication skills of children with ADHD. We aim to do this by using: the context of play, parents, children's typically-developing playmates and therapist supported clinic sessions. We suspect, that both children with ADHD and their playmates will demonstrate significant improvements in their social and communication skills following the intervention and that these skills will also be observed in the home environment. We suspect parents may also find the intervention a supportive approach that assists them to develop their child's social and communication skills which are needed for friendships.

  • A pragmatic randomised trial of an intervention to increase childcare service implementation of healthy eating and physical activity promoting policies and practices

    Implementing initiatives to promote healthy eating and physical activity in childcare services has been identified as a priority to prevent excessive child weight gain. Despite this, few trials have been conducted to assess the effectiveness of interventions to support population-wide implementation of such initiatives. The aim of this study is to assess the effectiveness and acceptability of a performance review and feedback intervention, targeting childcare service staff, in increasing the implementation of healthy eating and physical activity promoting policies and practices.

  • vaxSMS: A randomised controlled trial of text messaging and calendar reminders for improving immunisation timeliness in areas of low immunisation coverage

    We are evaluating the effectiveness of a tablet computer application (app), which provides SMS and calendar reminders, in encouraging on time immunisation.

  • Pathogenesis of long bone fractures in Vitamin D deficient children

    Peripheral quantitative computed tomography (pQCT) is a novel tool that has the ability to assess trabecular bone independently of cortical bone, and to evaluate various measures of macroscopic bone geometry, which can be combined into indices of bone strength. A randomised, placebo control trial of vitamin D treatment versus placebo will be performed. Muscle strength and cross sectional muscle area will also be assessed at each follow up time point for all eligible patients.

  • THE HEP573 STUDY: A randomised, double-blind, placebo-controlled clinical trial of silymarin alone, and silymarin combined with antioxidants in chronic hepatitis C

    Oxidative stress (OS) is a key mechanism by which liver injury occurs in chronic hepatitis C (CHC) virus infection. For this Study, it was hypothesised the use of antioxidant compounds would reduce OS, hepatic necroinflammation and hepatic fibrosis in CHC patients. To test this hypothesis, a randomised, double-blind, placebo-controlled clinical trial (termed the Hep573 Study) was conducted in three Australian teaching hospitals in New South Wales. One hundred and eighteen participants were recruited through the liver outpatient clinics at the hospitals from July, 2003 to March, 2006. They were randomised to treatment in blocks of six to one of three groups: placebo; silymarin (720 mg silybin/day); and silymarin with antioxidants (720 mg silybin plus 12 other ingredients). Study duration was 48 weeks: 24 weeks on active treatment or placebo, and 24 weeks follow-up post treatment. The primary outcome measure was the proportion of patients with alanine aminotransferase (ALT) normalisation at Week 24 (Fisher's exact test). Secondary outcome measures were the percentage change from baseline to Week 24 in F2-isoprostanes, and to Week 24 and Week 48 in ALT, HCV viral load (HCV RNA), FibroTest and Hepascore (Linear Mixed Effects). Results were analysed on an intention-to-treat basis. In patients with compensated CHC, the use of silymarin and antioxidant compounds achieved a higher rate of ALT normalisation than placebo (P=0.02) or silymarin (P=0.003) at Week 24. This result could not be attributed to alcohol, diet or caffeine, as intake across the groups did not change throughout the Study. In addition, there was a significant improvement in the overall mental-health score (Mental Component Summary), QualityMetric Hepatitis Quality of Life Questionnaire Trademark (HQLQ) in the silymarin and antioxidant (SOX) group (P=0.002). This novel randomised, double-blind, placebo-controlled trial of oral silymarin and oral antioxidants has shown a reduction in hepatic necroinflammation and an improvement in overall mental-health status in a specific CHC population.

Tags:
  • Finding clinical trials